These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 731425)

  • 1. The effect of isoniazid and other drugs on the acetylation of procainamide in the intact rat.
    Sprouse JS; Schneck DW; Hayes AH
    J Pharmacol Exp Ther; 1978 Dec; 207(3):698-704. PubMed ID: 731425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The quantitative disposition of procainamide and N-acetylprocainamide in the rat.
    Schneck DW; Grove K; Dewitt FO; Shiroff RA; Hayes AH
    J Pharmacol Exp Ther; 1978 Jan; 204(1):219-25. PubMed ID: 619132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of hydralazine and other drugs on the kinetics of procainamide acetylation by rat liver and kidney N-acetyltransferase.
    Schneck DW; Sprouse JS; Hayes AH; Shiroff RA
    J Pharmacol Exp Ther; 1978 Jan; 204(1):212-8. PubMed ID: 619131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of procainamide N-acetylation in the rat in vivo and in the perfused rat liver preparation.
    Pang KS; Huang JC; Finkle C; Kong P; Cherry WF; Fayz S
    Drug Metab Dispos; 1984; 12(3):314-22. PubMed ID: 6203693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disposition of procainamide and N-acetylprocainamide in protein-calorie malnutrition.
    Jung D; Nanavaty M; Prasad P
    Drug Metab Dispos; 1985; 13(3):359-63. PubMed ID: 2410212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of coadministration of procainamide and isoniazid on each other's acetylation pathway.
    Schneck DW; Sprouse JS; Shiroff RA; Vary JE; DeWitt FO; Hayes AH
    Pharmacology; 1979; 18(1):34-41. PubMed ID: 419159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of exercise on plasma levels and urinary excretion of sulphadimidine and procainamide.
    Ylitalo P; Hinkka H
    Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):548-53. PubMed ID: 4066079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic studies of procainamide (PA) and N-acetylprocainamide (NAPA) in healthy subjects.
    Wierzchowiecki M; Michałowska D; Lowicki Z; Ochotny R; Grześkowiak A; Tomaszkiewicz T
    Int J Clin Pharmacol Ther Toxicol; 1980 Jun; 18(6):272-6. PubMed ID: 6161089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetylation of procainamide in man and its relationship to isonicotinic acid hydrazide acetylation phenotype.
    Gibson TP; Matusik J; Matusik E; Nelson HA; Wilkinson J; Briggs WA
    Clin Pharmacol Ther; 1975 Apr; 17(4):395-9. PubMed ID: 1122681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of isoniazid on the metabolism of 14C-diphenylhydantoin in rats.
    Buttar HS; Wong LT; Moffatt JH
    Arch Int Pharmacodyn Ther; 1978 Sep; 235(1):9-18. PubMed ID: 736695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procainamide and N-acetylprocainamide kinetics investigated simultaneously with stable isotope methodology.
    Dutcher JS; Strong JM; Lucas SV; Lee WK; Atkinson AJ
    Clin Pharmacol Ther; 1977 Oct; 22(4):447-57. PubMed ID: 902457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of isoniazid on hepatic drug oxidation and N-acetylation capacities in rats.
    Desta Z; Siegmund W; Franke G; Beyrich A; Bleyer H
    Pharmazie; 1992 Jun; 47(6):448-51. PubMed ID: 1409842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procainamide pharmacokinetics in beagles: urinary pH dependency and comparison with n-acetylprocainamide.
    Baer DT; Barkus JC
    Res Commun Chem Pathol Pharmacol; 1977 Jun; 17(2):333-6. PubMed ID: 17895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacokinetics of procainamide and its metabolite depending on acetylator phenotype].
    Gawrońska-Szklarz B; Górnik W; Kutrzeba J; Wójcicki J; Zakrzewski J
    Pol Tyg Lek; 1992 Oct 5-12; 47(40-41):921-3. PubMed ID: 1284448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of procainamide and N-acetylprocainamide in renal failure.
    Gibson TP; Atkinson AJ; Matusik E; Nelson LD; Briggs WA
    Kidney Int; 1977 Dec; 12(6):422-9. PubMed ID: 609192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in biliary excretory function by streptozotocin-induced diabetes.
    Watkins JB; Dykstra TP
    Drug Metab Dispos; 1987; 15(2):177-83. PubMed ID: 2882974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of desethyl procainamide in patients: a new metabolite of procainamide.
    Ruo TI; Morita Y; Atkinson AJ; Henthorn T; Thenot JP
    J Pharmacol Exp Ther; 1981 Feb; 216(2):357-62. PubMed ID: 6162026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Procainamide, N-acetylprocainamide, antinuclear antibody and systemic lupus erythematosus.
    Reidenberg MM; Drayer DE
    Angiology; 1986 Dec; 37(12 Pt 2):968-71. PubMed ID: 2433971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of procainamide in the perfused rat liver.
    Uetrecht JP; Woosley RL; Freeman RW; Sweetman BJ; Oates JA
    Drug Metab Dispos; 1981; 9(3):183-7. PubMed ID: 6166441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of procainamide hydrochloride in dogs.
    Papich MG; Davis LE; Davis CA; McKiernan BC; Brown SA
    Am J Vet Res; 1986 Nov; 47(11):2351-8. PubMed ID: 2431636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.